Some European countries, including Norway, Iceland, Austria, Estonia, Lithuania, Luxembourg, Italy, and Latvia, have suspended the use of AstraZeneca vaccine following reports that it is causing blood clots in patients.
Denmark has temporarily suspended the use of the vaccine after the Danish Health Authority reported that one person died after receiving the vaccine.
The country’s government said it is not completely terminating the use of the vaccine but only temporarily halting it for two weeks while the case is being investigated.
“It is important to point out that we have not terminated the use of the AstraZeneca vaccine—we are just pausing its use,” said the Danish Health Authority’s director, Soren Brostrøm.
Another Europian country, Austria, has also suspended the use of AstraZeneca vaccine after one person was diagnosed with multiple thrombosis and died 10 days after receiving the vaccine.
The Nigerian health authorities have maintained that the batch of AstraZeneca vaccine (ABV5300) recently delivered into the country is safe to use and has no side effect.
NPHCDA’s director, Dr Faisal Shuaib, said no vaccinated person has reported any serious side effects since the vaccination commenced.
Dr Shuaib said that all reported side effects have been mild.
